These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 5335647)
1. Activity of repository sulfones against Mycobacterium leprae in mice. Shepard CC Proc Soc Exp Biol Med; 1967 Feb; 124(2):430-3. PubMed ID: 5335647 [No Abstract] [Full Text] [Related]
2. Drug resistance of Mycobacterium leprae, particularly to DDS. Rees RJ Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566 [No Abstract] [Full Text] [Related]
3. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment. Shepard CC; Levy L; Fasal P Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029 [No Abstract] [Full Text] [Related]
4. Drug resistance in leprosy. Browne SG Lepr Rev; 1974 Sep; 45(3):276-8. PubMed ID: 4612275 [No Abstract] [Full Text] [Related]
5. Chemotherapy of leprosy. Shepard CC Annu Rev Pharmacol; 1969; 9():37-50. PubMed ID: 4892433 [No Abstract] [Full Text] [Related]
6. Potential antileprotic agents. 1. Inhibition of a model mycobacterial system by diaryl sulfones. Colwell WT; Chan G; Brown VH; DeGraw JI; Peters JH; Morrison NE J Med Chem; 1974 Jan; 17(1):142-4. PubMed ID: 4585972 [No Abstract] [Full Text] [Related]
7. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report. Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722 [No Abstract] [Full Text] [Related]
8. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses. Browne SG Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048 [No Abstract] [Full Text] [Related]
9. Mode of action of sulphones. Bergel M Nihon Rai Gakkai Zasshi; 1984; 53(4):214-5. PubMed ID: 6399286 [No Abstract] [Full Text] [Related]
10. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411 [No Abstract] [Full Text] [Related]
11. Dapsone-resistant leprosy in Jakarta: a preliminary report. Utji R; Kosasih A; Santoso AU Lepr Rev; 1983 Sep; 54(3):193-5. PubMed ID: 6355723 [No Abstract] [Full Text] [Related]
12. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae. Pattyn SR Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832 [No Abstract] [Full Text] [Related]
13. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy. Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of secondary dapsone-resistant leprosy in Upper Volta. Pattyn SR; Yada A; Sansarricq H; van Loo L Lepr Rev; 1984 Dec; 55(4):361-7. PubMed ID: 6396476 [No Abstract] [Full Text] [Related]
18. Drug susceptibility testing of Mycobacterium leprae. Baohong J Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):830-5. PubMed ID: 3325575 [No Abstract] [Full Text] [Related]
19. Dapsone-resistant leprosy in a population of Bamako (Mali). Baquillon G; Ferracci C; Saint Andre P; Pattyn SR Lepr Rev; 1980 Dec; 51(4):315-9. PubMed ID: 7012500 [No Abstract] [Full Text] [Related]
20. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae. Dhople AM Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]